Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Late impact of preformed anti-HLA antibodies on kidney graft outcome.

da Silva CK, Meinerz G, Bruno RM, Abud J, Montagner J, Dorsdt DMB, Coutinho AK, Neumann J, Garcia VD, Keitel E.

Transpl Immunol. 2019 Aug;55. pii: S0966-3274(18)30136-9. doi: 10.1016/j.trim.2019.06.004. Epub 2019 Jun 27. No abstract available.

PMID:
31254612
2.

Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.

Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.

Transpl Immunol. 2015 Mar;32(2):66-71. doi: 10.1016/j.trim.2015.01.002. Epub 2015 Feb 7.

PMID:
25661873
3.

Kidney graft failure and presensitization against HLA class I and class II antigens.

Süsal C, Opelz G.

Transplantation. 2002 Apr 27;73(8):1269-73.

PMID:
11981420
4.

Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity.

Sánchez-Zapardiel E, Castro-Panete MJ, Mancebo E, Morales P, Laguna-Goya R, Morales JM, Apaza J, de Andrés A, Talayero P, Paz-Artal E.

Nephrol Dial Transplant. 2016 Jan;31(1):150-60. doi: 10.1093/ndt/gfv308. Epub 2015 Aug 30.

PMID:
26323481
5.

Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.

Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P.

Transplantation. 2016 Jan;100(1):159-66. doi: 10.1097/TP.0000000000000821.

PMID:
26262501
6.

Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?

Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.

Hum Immunol. 2017 Sep;78(9):526-533. doi: 10.1016/j.humimm.2017.07.011. Epub 2017 Jul 19.

PMID:
28732720
7.

Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival.

Redondo-Pachón D, Pascual J, Pérez-Sáez MJ, García C, Hernández JJ, Gimeno J, Mir M, Crespo M.

Transpl Immunol. 2016 Feb;34:1-7. doi: 10.1016/j.trim.2015.11.002. Epub 2015 Nov 18.

PMID:
26603314
8.

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients.

de Sousa MV, Gonçalez AC, Zollner RL, Mazzali M.

Ann Transplant. 2018 Jul 6;23:457-466. doi: 10.12659/AOT.908491.

9.

Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.

Reed E, Hardy M, Benvenisty A, Lattes C, Brensilver J, McCabe R, Reemstma K, King DW, Suciu-Foca N.

N Engl J Med. 1987 Jun 4;316(23):1450-5.

PMID:
3553951
10.

Influence of preformed donor-specific antibodies and C4d on early liver allograft function.

Perera MT, Silva MA, Murphy N, Briggs D, Mirza DF, Neil DA.

Scand J Gastroenterol. 2013 Dec;48(12):1444-51. doi: 10.3109/00365521.2013.845795. Epub 2013 Oct 16.

PMID:
24131305
11.

Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study.

Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Görg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, König IR, Kurschat C, Lehmann C, Marget M, Mühlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Süsal C, Thiele B, Zecher D, Lachmann N.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1056-1066. doi: 10.2215/CJN.13401118. Epub 2019 Jun 18.

PMID:
31213508
12.
13.

Anti-HLA antibodies in kidney transplanted patients.

Maccarone D, Cervelli C, Parzanese I, Pisani F, Caniglia L, Rascente M, Battistoni C, Famulari A, Adorno D.

Transplant Proc. 2005 Jul-Aug;37(6):2459-60.

PMID:
16182708
14.

Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome.

Molina J, Navas A, Agüera ML, Rodelo-Haad C, Alonso C, Rodríguez-Benot A, Aljama P, Solana R.

Front Immunol. 2017 Oct 31;8:1310. doi: 10.3389/fimmu.2017.01310. eCollection 2017.

15.

Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.

Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.

Nephrol Dial Transplant. 2012 Mar;27(3):1231-8. doi: 10.1093/ndt/gfr429. Epub 2011 Aug 2.

PMID:
21810767
16.

Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.

Castillo-Rama M, Castro MJ, Bernardo I, Meneu-Diaz JC, Elola-Olaso AM, Calleja-Antolin SM, Romo E, Morales P, Moreno E, Paz-Artal E.

Liver Transpl. 2008 Apr;14(4):554-62. doi: 10.1002/lt.21408.

17.

Anti-HLA and anti-MICA antibodies in liver transplant recipients: effect on long-term graft survival.

Ciszek M, Foroncewicz B, Mucha K, Żochowska D, Ziarkiewicz-Wróblewska B, Krawczyk M, Pączek L.

Clin Dev Immunol. 2013;2013:828201. doi: 10.1155/2013/828201. Epub 2013 Nov 24.

18.

Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation.

Visentin J, Marroc M, Guidicelli G, Bachelet T, Nong T, Moreau JF, Lee JH, Merville P, Couzi L, Taupin JL.

Clin Transplant. 2015 May;29(5):393-402. doi: 10.1111/ctr.12529. Epub 2015 Mar 13.

PMID:
25683727
19.

Different impact of pretransplant anti-HLA antibodies detected by Luminex in highly sensitized renal transplanted patients.

Pérez-Flores I, Santiago JL, Calvo-Romero N, Barrientos-Guzmán A, Sánchez-Fructuoso AI.

Biomed Res Int. 2013;2013:738404. doi: 10.1155/2013/738404. Epub 2013 Sep 5.

20.

Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes.

Redondo-Pachón D, Pérez-Sáez MJ, Mir M, Gimeno J, Llinás L, García C, Hernández JJ, Yélamos J, Pascual J, Crespo M.

Hum Immunol. 2018 Jun;79(6):424-431. doi: 10.1016/j.humimm.2018.02.014. Epub 2018 Mar 7.

PMID:
29524568

Supplemental Content

Support Center